Brain dopamine signaling is essential for the motivation to eat, and obesity is associated with altered dopaminergic signaling and increased food craving. We used molecular neuroimaging to explore whether striatal dopamine transporter (DAT) availability is associated with craving as measured with the General Food Craving Questionnaire-Trait (G-FCQ-T). We here show that humans with obesity ( = 34) experienced significantly more craving for food compared with lean subjects ( = 32), but food craving did not correlate significantly with striatal DAT availability as assessed with I-FP-CIT single-photon emission computed tomography. We conclude that food craving is increased in obesity, but the scores for food craving are not related to changes in striatal DAT availability.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615750 | PMC |
http://dx.doi.org/10.3390/brainsci11111428 | DOI Listing |
Sci Rep
December 2024
Department of Psychiatry, Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Food craving is a common phenomenon during pregnancy. This behaviour may be influenced by personality traits that have been known to be linked with obesity and addiction affecting pregnancy outcomes. We identified the prevalence of food cravings and evaluated its relationship with personality traits in pregnant women.
View Article and Find Full Text PDFCureus
November 2024
School of Public Health, Loma Linda University, Loma Linda, USA.
Introduction: Variation in common taste receptor type 2 member 38 (TAS2R38) haplotypes is associated with bitter taste sensitivity, but there is not much or inconsistent evidence on association with food cravings and with chronic disease risk factors. We have conducted a cross-sectional study to assess whether genetically defined taster groups would differ in their sensitivity to bitter-tasting compounds, cravings for various food groups, and risk of chronic disease risk factors. Methodology: A total of 116 non-diabetic individuals were recruited from the Loma Linda University (LLU) campus.
View Article and Find Full Text PDFCureus
November 2024
Psychiatry, Rajarajeswari Medical College & Hospital, Bengaluru, IND.
Background Food addiction (FA), where an individual displays a loss of control over the consumption of calorie-dense foods (refined carbohydrates, fats), is proposed to be like substance-use disorders with the experience of cravings, reduced control over intake, increased impulsivity, and altered reward-sensitivity. FA may also be associated with obesity. This study aimed to determine the prevalence of FA in urban and rural areas, and the proportion of obesity in young adults with FA.
View Article and Find Full Text PDFHealth Promot J Austr
January 2025
School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia.
Background: In Australia, there are concerns that unrestricted junk food advertising during sports broadcasts increases short-term junk food consumption among viewers. Therefore, the present study aimed to estimate the impact of junk food and anti-junk food advertising on consumption inclinations.
Methods: We conducted a content analysis across a sample (N = 16) of Australian Football League (AFL) and National Rugby League (NRL) matches to determine the prevalence of junk food and anti-junk food advertising video clips.
JCI Insight
December 2024
Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse (NIDA) Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism (NIAAA) Division of Intramural Clinical and Biological Research, NIH, Baltimore and Bethesda, Maryland, USA.
BACKGROUNDStudies have demonstrated the role of ghrelin in alcohol-related behaviors and consumption. Blockade of the growth hormone secretagogue receptor (GHSR), which is the ghrelin receptor, has been shown to decrease alcohol drinking and reward-related behaviors across several animal models. We previously conducted a human study testing a GHSR inverse agonist/competitive antagonist, PF-5190457, in individuals who are heavy drinkers and showed its safety when coadministered with alcohol.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!